@AMPath

We provide global expertise in molecular testing that drives patient care.

 Rockville, MD
amp.org
Joined September 2009
  • Tweets9.8K
  • Following3.5K
  • Followers9.4K
🎤 Calling all AMP trainees with talent! Perform in the #AMP2026 talent show and receive a complimentary ticket to the Amazing Molecular Party on Nov. 13! Email [email protected] by Oct. 30 with your proposed act (five minutes maximum).
AMP Annual Meeting & Expo 26 in Seattle, Nov 10-14, 2026, invites talented trainees to perform at the Amazing Molecular Party with free attendance.

ALT AMP Annual Meeting & Expo 26 in Seattle, Nov 10-14, 2026, invites talented trainees to perform at the Amazing Molecular Party with free attendance.

1
175
Join us Oct. 29 at 1 p.m. Eastern for a free webinar exploring ctDNA-based MRD detection and its potential applications in risk stratification, surveillance and treatment selection. educate.amp.org/local/catalo…
Webinar on minimal residual disease in solid tumors featuring experts from Johns Hopkins and University of Minnesota, discussing circulating tumor DNA.

ALT Webinar on minimal residual disease in solid tumors featuring experts from Johns Hopkins and University of Minnesota, discussing circulating tumor DNA.

3
177
In leukemia testing, molecular labs face a difficult trade-off: broad detection of fusions and mutations or the deep sensitivity required for MRD. Watch this OCW to explore how @countablelabs' single-molecule counting assays are designed to address both. player.vimeo.com/video/12310…
4
9
419
New AMP case report in CAP Today: "Comprehensive Molecular Characterization of an Aggressive Infant-Type Hemispheric Glioma with a Novel PRKAR2A::ALK Fusion" 👉 amp.org/AMP/assets/File/clin…
CAP TODAY (October 2026 issue) featuring a report on molecular characterization of aggressive infant-type hemispheric glioma with PRKAR2A::ALK fusion.

ALT CAP TODAY (October 2026 issue) featuring a report on molecular characterization of aggressive infant-type hemispheric glioma with PRKAR2A::ALK fusion.

3
2
309
🗓️ Today’s the last day to register for #AMP2026 at the standard registration rate. Register by 11:59 p.m. Eastern to save. Don’t wait until it’s too late! Register: ow.ly/WwAW50ZVvY3
AMP Annual Meeting & Expo 26 in Seattle, November 10-14, 2026, focusing on data transforming molecular medicine.

ALT AMP Annual Meeting & Expo 26 in Seattle, November 10-14, 2026, focusing on data transforming molecular medicine.

1
3
5
242
Today: Join us along with @ToniSepulvedaMD for a free webinar on alternative workflows for ordering biomarker and NGS tumor testing in colorectal and other gastrointestinal cancers covering multiple models and evaluate how these approaches affect outcomes. educate.amp.org/local/catalo…
Banner for AMP webinar on precision oncology testing protocols scheduled for Oct 20, 2026, featuring Dr. Antonia R. Sepulveda from George Washington University.

ALT Banner for AMP webinar on precision oncology testing protocols scheduled for Oct 20, 2026, featuring Dr. Antonia R. Sepulveda from George Washington University.

1
2
3
230
📅 Oct. 28 | 🕒 1 p.m. Eastern ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies (hosted by Invivoscribe) Register for free: us06web.zoom.us/webinar/regi…
Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

ALT Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

2
5
400
🧛 Transform hematologic diagnostics with your molecular insights. @JMDiagn invites papers on NGS panels, fusion detection, MRD and molecular testing in leukemias, lymphomas and related disorders. Submit here: editorialmanager.com/jmdi/de…
Microscopic images of blood cells and tissues promoting JMD for advancements in hematopathology diagnostics.

ALT Microscopic images of blood cells and tissues promoting JMD for advancements in hematopathology diagnostics.

4
8
427
Advocacy update: In a letter, 19 members of Congress have urged CMS not to make unilateral changes to surgical pathology service valuations in the 2027 Medicare Physician Fee Schedule. Read the letter: amp.org/AMP/assets/File/advo…
2
1
3
370
➡️ Sunday: Last day to book your #AMP 2026 room with our discount. Hotel information: ow.ly/qBox50ZYeuY ➡️ Tuesday: Last day for regular registration. After that, the (higher) on-site rate applies. Register: ow.ly/Wk6h50ZYev0
Logo for AMP 2026 Annual Meeting & Expo in Seattle, Nov 10-14, 2026, promoting research in precision medicine and patient outcomes.

ALT Logo for AMP 2026 Annual Meeting & Expo in Seattle, Nov 10-14, 2026, promoting research in precision medicine and patient outcomes.

2
340
Load more